v3.26.3
Condensed Consolidated Statements of Earnings - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]    
Revenue $ 67,513 $ 64,009
Cost of Product and Service Sold 64,917 61,690
Gross margin 2,596 2,319
Operating expenses:    
Selling, General and Administrative Expense 1,595 1,461
Restructuring and employee severance 23 20
Amortization and other acquisition-related costs 182 104
Acquisition-related cash and share-based compensation costs 94 64
Impairments and (gain)/loss on disposal of assets, net (4) 2
Litigation (recoveries)/charges, net (47) 0
Operating earnings 753 668
Other (income)/expense, net (6) (10)
Interest expense, net 73 80
Equity Method Investment, Realized Gain (Loss) on Disposal (2) 0
Earnings before income taxes 688 598
Provision for income taxes 132 144
Net earnings 556 454
Less: Net earnings attributable to noncontrolling interests (2) (4)
Net earnings attributable to Cardinal Health, Inc. $ 554 $ 450
Earnings per common share attributable to Cardinal Health, Inc.:    
Basic (in shares) $ 2.39 $ 1.89
Diluted (in shares) $ 2.38 $ 1.88
Weighted-average number of common shares outstanding:    
Basic (in shares) 232,000 238,000
Diluted (in shares) 233,000 239,000
Cash dividends declared per common share $ 0.5158 $ 0.5107